Literature DB >> 8432210

Chromatid contamination can impair the purity of flow-sorted metaphase chromosomes.

H Telenius1, D de Vos, E Blennow, L R Willat, B A Ponder, N P Carter.   

Abstract

We describe a phenomenon where a second flow karyotype is superimposed on the normal metaphase flow karyotype of human lymphoblastoid chromosomes. The events of this second flow karyotype contain half the DNA content of corresponding events in the normal flow karyotype and, when sorted, show the morphology of single chromatids. DNA amplified by degenerate oligonucleotide-primed PCR of 300 chromatids sorted from a single peak and hybridized onto normal metaphase spreads painted the entire length of the corresponding chromosome type. In retrospect, we could observe this phenomenon at a low level in 37% of randomly selected, previously analyzed flow karyotypes and in several published flow karyotypes from other laboratories. Experimentally, chromatid frequency was shown to vary with the colcemid blocking conditions as well as with the cell line used. At the extreme, we obtained a 4:10 ratio of chromatids to metaphase chromosomes, whereas this could be reduced tenfold by altering the colcemid blocking conditions in the same cell line. The presence of chromatids in chromosome preparations has important implications for the purity of isolated fractions used for generating libraries and in PCR analysis.

Entities:  

Mesh:

Year:  1993        PMID: 8432210     DOI: 10.1002/cyto.990140116

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  2 in total

1.  Array painting: a protocol for the rapid analysis of aberrant chromosomes using DNA microarrays.

Authors:  Susan M Gribble; Bee Ling Ng; Elena Prigmore; Tomas Fitzgerald; Nigel P Carter
Journal:  Nat Protoc       Date:  2009-11-05       Impact factor: 13.491

Review 2.  Chromosomes in the flow to simplify genome analysis.

Authors:  Jaroslav Doležel; Jan Vrána; Jan Safář; Jan Bartoš; Marie Kubaláková; Hana Simková
Journal:  Funct Integr Genomics       Date:  2012-08-16       Impact factor: 3.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.